- Home
- A-Z Publications
- Current Hypertension Reviews
- Previous Issues
- Volume 3, Issue 2, 2007
Current Hypertension Reviews - Volume 3, Issue 2, 2007
Volume 3, Issue 2, 2007
-
-
Silent Cerebral Damage in Hypertension
Authors: Cristina Sierra and Antonio CocaStroke is the third most-frequent cause of death after cancer and heart disease in developed countries, and is one of the most common reasons for developing cognitive impairment and vascular dementia. Hypertension is known to be the most important factor for developing stroke and vascular dementia. In addition, the presence of cerebral white matter lesions (WML) is an important prognostic factor for the development of str Read More
-
-
-
Reliability of Blood Pressure Patterns Defined by a Single 24-Hour Ambulatory Blood Pressure Monitoring: The Case of the Dipping/Non Dipping and Isolated Clinic Hypertension
Authors: Cesare Cuspidi, Carla Sala, Alberto Zanchetti and Giuseppe ManciaClassification of hypertensive subjects according to different blood pressure patterns : i.e sustained vs isolated clinic hypertension (ICH) , dipping vs non dipping is now regarded as a useful mean for a more precise individual risk stratification and therapeutic making decisions. However, this subdivision is routinely based on a single ambulatory blood pressure monitoring (ABPM), despite the well-known day-to-day variability in Read More
-
-
-
Hypothyroidism and Atherosclerosis-Possible Implication of the Renin-Angiotensin System
More LessClinical and autopsy studies have suggested that patients with hypothyroidism have more advanced coronary atherosclerosis. The accelerated atherosclerosis has been explained by increases in low density lipoprotein cholesterol, blood pressure and newer risk factors such as homocysteine, C-reactive protein and plasminogen activator inhibitor-1 in hypothyroid state. In addition, recent studies have suggested that thyroid hor Read More
-
-
-
Interplay Between ACE2 and Angiotensin-(1-7) in the Regulation of Blood Pressure
Authors: Carlos M. Ferrario and Jewell A. JessupThe primacy of angiotensin II (Ang II) as the critical component mediating the multiple biological actions of the renin angiotensin system is undergoing a critical revision given the growth of the biochemical and physiological evidence demonstrating the existence of other proteins that, within the system, lead to the formation of alternate forms of angiotensin peptides. The persistent notion that Ang II is at the center of t Read More
-
-
-
Brain Angiotensin and Cardiovascular Reactivity to Negative and Positive Emotional Stress
More LessCardiovascular reactivity, an abrupt increase in blood pressure and heart rate in response to negative emotional stress is a risk factor for hypertension and heart disease. Brain angiotensin II (Ang II) has been recognized as an important regulator of cardiovascular reactivity. Apart from threatening events, exposure to appetitive stimuli is capable of inducing a distinct, sympathetically mediated rise in blood pressure in bo Read More
-
-
-
Detection and Treatment of Alcohol-Induced Hypertension
Authors: Scott H. Stewart and Peter M. MillerHeavy alcohol use causes or exacerbates a number of medical conditions. In particular, hypertension (HTN), the most common primary diagnosis in primary care, is particularly alcohol-sensitive. In patients with HTN, excessive alcohol use (3 or more drinks a day) can interfere with successful blood pressure control and facilitate disease complications. Excessive alcohol use is one of 6 major causes of treatment-resistant HTN. T Read More
-
-
-
Potential Contribution of Action of Renin Angiotensin System to Bone Metabolism
Authors: Hironori Nakagami, Mariana Kiomy Osako, Hideo Shimizu, Rie Hanayama and Ryuichi MorishitaBone metabolism is closely regulated by hormones and cytokines, which have effects on both bone resorption and deposition. Since renin-angiotensin system (RAS) has been known to play an important role to regulate remodeling in several tissues, we focused on the potential role of RAS in bone metabolism. It is known that the receptors of angiotensin II are expressed in culture osteoclasts and osteoblasts, and angiot Read More
-
-
-
EarlyVascularAgeing and Hypertension -A New Model for Understanding Cardiovascular Risk
More LessMany individuals do not appear to have matching chronological and biological age, as evaluated by their general outlook, physical examination, or clinical investigations. One aspect of this is the concept of early vascular ageing. This could be useful both in research and clinical practice to understand and treat the increased cardiovascular risk in many patients, e.g. with hypertension in poor control. New ways of measuring Read More
-
-
-
Hypertensive Heart Disease and the Role of Aldosterone Antagonists
Authors: Chanwit Roongsritong, Ashwani Kumar and Leigh Ann JenkinsHypertensive heart disease (HHD) encompasses a spectrum of abnormalities resulting from structural and functional adaptations to chronic pressure overload. The clinical manifestations of HHD range from asymptomatic left ventricular hypertrophy (LVH) to symptomatic heart failure. HHD has been associated with increased risk of cardiovascular morbidity and all cause mortality. However, regression of LVH by antihyp Read More
-
-
-
Aldosterone and Resistant Hypertension
Authors: Andrea Semplicini, Michelangelo Sartor and Lorenzo A. CaloRefractory or resistant hypertension, defined as the failure to control systolic (<140 mmHg) and/or diastolic blood pressure (< 90 mmHg) despite the use of three or more different classes of antihypertensive agents, is a common problem in clinical practice. Several factors induce treatment resistance, especially secondary hypertension, such as primary aldosteronism. Some authors have argued for a direct role of aldosteron Read More
-
-
-
Anti-Vascular Endothelial Growth Factor (VEGF) Therapy: A New Cause of Hypertension
Authors: Xiaolei Zhu and Mark A. PerazellaVascular endothelial growth factor (VEGF) is a potent angiogenic factor that has multiple effects on the vascular endothelium and many other cells. Many cancers utilize VEGF for proliferation, progression and metastasis, making it a logical target of anti-tumor therapy. Numerous clinical oncology trials have employed this therapeutic approach to effectively treat various malignancies. Hypertension has emerged as one of the most Read More
-
Volumes & issues
-
Volume 21 (2025)
-
Volume 20 (2024)
-
Volume 19 (2023)
-
Volume 18 (2022)
-
Volume 17 (2021)
-
Volume 16 (2020)
-
Volume 15 (2019)
-
Volume 14 (2018)
-
Volume 13 (2017)
-
Volume 12 (2016)
-
Volume 11 (2015)
-
Volume 10 (2014)
-
Volume 9 (2013)
-
Volume 8 (2012)
-
Volume 7 (2011)
-
Volume 6 (2010)
-
Volume 5 (2009)
-
Volume 4 (2008)
-
Volume 3 (2007)
-
Volume 2 (2006)
-
Volume 1 (2005)
Most Read This Month
Article
content/journals/chyr
Journal
10
5
false
en
